Parametrica Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,778
Closed -$299K 110
2022
Q2
$299K Buy
1,778
+558
+46% +$120K 0.33% 79
2022
Q1
$306K Buy
+1,220
New +$306K 0.23% 115
2020
Q4
Sell
-9,014
Closed -$1.12M 178
2020
Q3
$1.12M Sell
9,014
-10,758
-54% -$1.33M 2.12% 14
2020
Q2
$1.92M Buy
19,772
+17,385
+728% +$1.81M 2.1% 10
2020
Q1
$214K Buy
+2,387
New +$309K 0.22% 166
2018
Q3
Sell
-2,128
Closed -$218K 172
2018
Q2
$218K Sell
2,128
-1,150
-35% -$116K 1.03% 38
2018
Q1
$318K Buy
+3,278
New +$318K 0.39% 101
2017
Q4
Sell
-3,751
Closed -$299K 408
2017
Q3
$299K Buy
+3,751
New +$302K 0.13% 191
2016
Q3
Sell
-3,543
Closed -$273K 178
2016
Q2
$273K Buy
+3,543
New +$280K 0.41% 119
2013
Q3
Sell
-6,507
Closed -$235K 45
2013
Q2
$235K Buy
+6,507
New +$252K 5.84% 8

Other funds holding HCA

Parametrica Management's HCA Position: Q3 2022 in Review

Parametrica Management sold out of HCA Healthcare (HCA) in Q3 2022, closing a stake of 1,778 shares — an estimated $299K sold.

Parametrica Management first reported a position in HCA in Q2 2013 and held it in 10 quarters. The position peaked at $1.92M in Q2 2020. 868 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • Parametrica Management reported no remaining HCA Healthcare position as of Q3 2022 after selling out during the quarter.
  • Parametrica Management sold 1,778 HCA Healthcare shares in Q3 2022, an estimated $299K.
  • Parametrica Management first reported a position in HCA Healthcare in Q2 2013 and held it in 10 quarters.
  • Parametrica Management's HCA Healthcare position peaked at $1.92M in Q2 2020.
  • 868 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.